Josep Domingo-Domenech

Department of Pathology, Icahn School of Medicine at Mount Sinai

Affiliated withIcahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai

Research Area

MedicineCancer Research

Biography

Josep Domingo-Domenech has not added Biography.
If you are Josep Domingo-Domenech and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 4	Year
Publication title	2014
Publication title	2015
Publication title	2017
Publication title	2019

Other Publications

Article	Year
[Fulminant hepatic failure as form of presentation of a peripheral T cell lymphoma]. Medicina clínica\| PubMed ID: 12459111	2002
Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur. Oncology\| PubMed ID: 15218314	2004
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells. Molecular cancer therapeutics\| PubMed ID: 16546981	2006
Whole brain irradiation and temozolomide based chemotherapy in melanoma brain metastases. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 16648102	2006
Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel anti... Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17000695	2006
Clinical outcome after surgical resection of lung metastases from melanoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 17272230	2007
Toxicity of combined treatment of adjuvant irradiation and interferon alpha2b in high-risk melanoma patients. Melanoma research\| PubMed ID: 17885585	2007
Prognostic implications of protein S-100beta serum levels in the clinical outcome of high-risk melanoma patients. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine\| PubMed ID: 17962723	2007
Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells. Breast cancer research and treatment\| PubMed ID: 18064564	2008
Loco-regional control after postoperative radiotherapy for patients with regional nodal metastases from melanoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 19828412	2009
Molecular pathways of urothelial development and bladder tumorigenesis. Urologic oncology\| PubMed ID: 20610278	2010
Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. The American journal of pathology\| PubMed ID: 21356385	2011
Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy. The Journal of urology\| PubMed ID: 21944130	2011
Anatomical features of the urethra and urinary bladder catheterization in female mice and rats. An essential translational tool. Acta cirúrgica brasileira / Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia\| PubMed ID: 22030824	2011
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 22374423	2012
A BAC-based transgenic mouse specifically expresses an inducible Cre in the urothelium. PloS one\| PubMed ID: 22496911	2012
Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer cell\| PubMed ID: 22975379	2012
A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells. The American journal of pathology\| PubMed ID: 23410519	2013
Advances in the management of muscle-invasive bladder cancer through risk prediction, risk communication, and novel treatment approaches. Clinical advances in hematology & oncology : H&O\| PubMed ID: 23598909	2013
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer. Cancer cell\| PubMed ID: 25670080	2015
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma. Gut\| PubMed ID: 26658144	2017
Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma. Oncology\| PubMed ID: 27077749	2016
Definitive Management of Primary Bladder Tumors in the Context of Metastatic Disease: Who, How, When, and Why? Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 27551117	2016
The role of GATA2 in lethal prostate cancer aggressiveness. Nature reviews. Urology\| PubMed ID: 27872477	2017
Targeting sarcoma tumor-initiating cells through differentiation therapy. Stem cell research\| PubMed ID: 28433655	2017